Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab for Vulnerable Plaque in ACS
NCT04719221Phase 4Unknown
- Sponsor
- Korea University Anam Hospital
- Start
- Mar 2021
- Primary completion
- Dec 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of evolocumab in acute coronary syndrome (ACS), sponsored by Korea University Anam Hospital. Status: unknown.
02
Drugs
evolocumab
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04719221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04719221.